10-K | 2020-12-31 | Filed 2021-02-23 |
10-Q | 2020-09-30 | Filed 2020-11-06 |
10-Q | 2020-06-30 | Filed 2020-08-05 |
10-Q | 2020-03-31 | Filed 2020-05-06 |
10-K | 2019-12-31 | Filed 2020-03-02 |
10-Q | 2019-09-30 | Filed 2019-11-08 |
10-Q | 2019-06-30 | Filed 2019-08-09 |
10-Q | 2019-03-31 | Filed 2019-05-10 |
10-K | 2018-12-31 | Filed 2019-02-27 |
10-Q | 2018-09-30 | Filed 2018-11-09 |
10-Q | 2018-06-30 | Filed 2018-08-03 |
10-Q | 2018-03-31 | Filed 2018-05-04 |
10-K | 2017-12-31 | Filed 2018-02-16 |
10-Q | 2017-09-30 | Filed 2017-11-03 |
10-Q | 2017-06-30 | Filed 2017-08-04 |
10-Q | 2017-03-31 | Filed 2017-05-05 |
10-K | 2016-12-31 | Filed 2017-02-16 |
10-Q | 2016-09-30 | Filed 2016-11-08 |
10-Q | 2016-06-30 | Filed 2016-08-09 |
10-Q | 2016-03-31 | Filed 2016-05-06 |
10-K | 2015-12-31 | Filed 2016-03-11 |
10-Q | 2015-09-30 | Filed 2015-11-12 |
10-Q | 2015-06-30 | Filed 2015-08-13 |
10-Q | 2015-03-31 | Filed 2015-05-14 |
10-K | 2014-12-31 | Filed 2015-03-19 |
10-Q | 2014-09-30 | Filed 2014-11-06 |
10-Q | 2014-06-30 | Filed 2014-08-07 |
10-Q | 2014-03-31 | Filed 2014-05-08 |
8-K | 2020-11-05 | |
8-K | 2020-08-04 | |
8-K | 2020-06-03 | |
8-K | 2020-05-05 | |
8-K | 2020-03-18 | |
8-K | 2020-02-12 | |
8-K | 2019-10-31 | |
8-K | 2019-08-09 | |
8-K | 2019-08-02 | |
8-K | 2019-06-03 | |
8-K | 2019-05-07 | |
8-K | 2019-02-12 | |
8-K | 2019-01-22 | |
8-K | 2018-11-19 | |
8-K | 2018-11-07 | |
8-K | 2018-07-31 | |
8-K | 2018-07-24 | |
8-K | 2018-06-05 | |
8-K | 2018-05-01 | |
8-K | 2018-02-13 |
Comps ($MM TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
---|---|---|---|---|---|---|---|---|---|---|---|
20 20 Global (TWGL) | |||||||||||
024 Pharma (EEIG) | |||||||||||
111 (YI) | 0% | 1,546 | 323 | 0 | 0 | 0 | 0 | -854 | |||
1 800 Flowers Com (FLWS) | 944 | 42% | 13.3 | 6% | 665 | 336 | 1,266 | 534 | 37 | 75 | 1,001 |
10x Genomics (TXG) | 4,805 | 75% | -490.3 | -2% | 573 | 151 | 61 | 46 | -10 | -9 | 4,357 |
12 Retech (RETC) | 0 | 32% | -0.1 | -1,385% | 1 | 20 | 1 | 0 | -15 | -15 | 1 |
11 Good Energy (ELVN) | |||||||||||
1347 Property Insurance Holdings (PIH) | 34 | 0% | 0.4 | -5% | 164 | 108 | 18 | 0 | -8 | -8 | -3 |
1347 Capital Corp (TFSC) | |||||||||||
180 Degree Capital (TURN) | |||||||||||
1847 Holdings (EFSH) | 25% | -2.4 | -15% | 19 | 23 | 27 | 7 | -3 | -1 | 3 | |
1895 Bancorp of Wisconsin (BCOW) | 46,153 | 12,508.1 | -0% | 441 | 383 | 0 | 0 | -0 | 4 | 46,142 | |
1st Constitution Bancorp (FCCY) | 165 | 0% | 4.4 | 1% | 1,343 | 1,204 | 0 | 0 | 14 | 33 | 144 |
1st Franklin Financial (FFC) | 4 | -0.6 | 7% | 905 | 645 | 0 | 0 | 62 | 80 | -46 | |
24 7 Kid Doc (TVMD) | |||||||||||
1st Source (SRCE) | 1,200 | 7.9 | 1% | 6,691 | 5,858 | 0 | 0 | 70 | 136 | 1,073 | |
2050 Motors (ETFM) | 0 | -0.2 | -166,272,400% | 0 | 2 | 0 | 0 | -2 | -2 | 0 | |
21Vianet Group (VNET) | 6,005 | 0% | 11,151 | 5,788 | 0 | 0 | 0 | 0 | 3,344 | ||
22nd Century (XXII) | 302 | 1% | -14.1 | -36% | 62 | 7 | 26 | 0 | -22 | -21 | 302 |
1Life Healthcare (ONEM) |
Balance Sheet ($MM) | 2014-03-31 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Cash | 221 | 222 | 193 | 201 | 202 | 210 | 190 | 135 | 124 | 131 | 92 | 106 | 130 | 135 | 159 | 335 | 330 | 308 | 288 | 302 | 286 | 254 | 238 |
Accounts Receivable | 40 | 44 | 48 | 51 | 48 | 49 | 53 | 63 | 58 | 61 | 67 | 72 | 72 | 75 | 78 | 81 | 86 | 96 | 106 | 112 | 108 | 108 | 117 |
Inventory | |||||||||||||||||||||||
PP&E | 47 | 48 | 50 | 52 | 54 | 55 | 61 | 61 | 64 | 64 | 66 | 65 | 67 | 67 | 67 | 68 | 68 | 72 | 72 | 72 | 75 | 76 | 77 |
Assets | 322 | 326 | 321 | 332 | 329 | 339 | 324 | 321 | 304 | 311 | 351 | 363 | 361 | 403 | 417 | 629 | 619 | 648 | 633 | 662 | 625 | 588 | 580 |
Accounts Payable | 7 | 8 | 6 | 6 | 6 | 10 | 9 | 8 | 8 | 6 | 6 | 5 | 4 | 4 | 4 | 6 | 3 | 4 | 10 | 17 | 17 | 22 | 17 |
Long-Term Debt | |||||||||||||||||||||||
Liabilities | 64 | 68 | 56 | 55 | 48 | 56 | 50 | 56 | 46 | 45 | 47 | 51 | 45 | 65 | 73 | 231 | 228 | 259 | 247 | 282 | 278 | 283 | 294 |
Stockholders' Equity | 258 | 258 | 264 | 277 | 281 | 283 | 275 | 265 | 258 | 266 | 304 | 312 | 316 | 337 | 343 | 398 | 391 | 389 | 387 | 380 | 347 | 305 | 286 |
Income Statement ($MM) | 2014-03-31 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Revenue | 52 | 52 | 59 | 60 | 56 | 56 | 56 | 69 | 66 | 67 | 66 | 75 | 73 | 74 | 82 | 93 | 87 | 90 | 104 | 107 | 98 | 105 | 115 |
Cost of Revenue | 21 | 21 | 23 | 22 | 22 | 22 | 23 | 25 | 25 | 25 | 35 | 29 | 29 | 30 | 38 | 44 | 40 | 48 | 57 | 61 | 57 | 64 | 70 |
Gross Profit | 31 | 31 | 35 | 38 | 34 | 34 | 34 | 44 | 41 | 42 | 31 | 46 | 43 | 44 | 44 | 49 | 46 | 42 | 47 | 46 | 41 | 41 | 44 |
R&D | 16 | 11 | 11 | 11 | 13 | 12 | 12 | 12 | 14 | 12 | 12 | 12 | 13 | 13 | 12 | 12 | 13 | 12 | 12 | 10 | 10 | 9 | 9 |
SG&A | 29 | 26 | 26 | 31 | 30 | 30 | 32 | 36 | 36 | 34 | 30 | 36 | 36 | 33 | 34 | 38 | 35 | 32 | 35 | 37 | 39 | 37 | 42 |
Tax | -0 | 0 | 1 | 1 | 0 | -1 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
Net Income | -14 | -7 | -1 | -2 | -4 | -9 | -10 | -4 | -8 | -4 | -11 | 4 | -3 | -6 | -11 | 4 | -11 | -5 | -8 | -4 | -13 | -4 | -10 |
Cash Flow ($MM) | 2014-03-31 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Cash Operating | 1 | 5 | -1 | -1 | 7 | -1 | 4 | 0 | 5 | 4 | 13 | -0 | 16 | 15 | 18 | -6 | 4 | 10 | 14 | 6 | |||
Cash Investing | -2 | -2 | -14 | 3 | -2 | -6 | -46 | -2 | -2 | -46 | -1 | 23 | -13 | 9 | -37 | 7 | -4 | 4 | -3 | -3 | |||
Cash Financing | 183 | -2 | -14 | -1 | 3 | -14 | -13 | -9 | 4 | 3 | 2 | 1 | 2 | -0 | 195 | -5 | -20 | -29 | -44 | -19 |